发明名称 Large conductance calcium-activated K channel opener
摘要 Disclosed are comopounds of formula (I) wherein X represents N-R 0 or S, R1 and R2 are different from each other and each independently represents hydrogen atom, a halogen atom, carboxyl group, a substituted or unsubstituted amino group, a substituted or unsubstituted lower alkyl group, a lower alkoxycarbonyl group, a substituted or unsubstituted lower alkenyl group, a cyclo-lower alkyl group, a substituted or unsubstituted carbamoyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted heterocyclic group-substituted carbonyl group, R3 represents a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted lower alkyl group, and R4 represents hydrogen atom or a substituted or unsubstituted lower alkyl group, or a pharmaceutically acceptable salt thereof, for use in the treatment or prophylaxis of a disease against which a large conductance calcium-activated K channel opening activity is efficacious.
申请公布号 NZ529043(A) 申请公布日期 2006.11.30
申请号 NZ20020529043 申请日期 2002.04.15
申请人 TANABE SEIYAKU CO 发明人 HONGU, MITSUYA;HOSAKA, TOSHIHIRO;KASHIWAGI, TOSHIHIKO;KONO, RIKAKO;KOBAYASHI, HIROYUKI
分类号 A61K31/00;A61K31/4164;A61K31/4178;A61K31/421;A61K31/422;A61K31/426;A61K31/427;A61K31/428;A61K31/4355;A61K31/4365;A61K31/437;A61K31/4439;A61K31/444;A61K31/4709;A61K31/4725;A61K31/497;A61K31/498;A61K31/506;A61P9/00;A61P9/10;A61P13/00;A61P13/02;A61P43/00;C07D233/54;C07D233/64;C07D233/68;C07D233/88;C07D263/30;C07D263/32;C07D263/34;C07D277/20;C07D277/30;C07D333/04;C07D333/28;C07D333/52;C07D401/04;C07D401/06;C07D401/14;C07D403/04;C07D405/04;C07D405/14;C07D409/04;C07D409/14;C07D413/04;C07D413/14;C07D417/04;C07D417/14;C07D471/04;C07D491/048;C07D495/04;(IPC1-7):A61K31/00;C07D417/00;A61K31/416;A61K31/417 主分类号 A61K31/00
代理机构 代理人
主权项
地址